A programme for the prevention of mother-to-child transmission of HIV (PMTCT) will continue in South Africa's Gauteng province, provincial health minister Gwen Ramokgopa has announced. Use of the anti-AIDS drug Nevirapine as a single dose in PMTCT programmes is currently under further research following claims by the Medicines Control Council (MCC) that the drug could create resistance in some HIV-positive expectant mothers.